Anzeige
Mehr »
Login
Donnerstag, 18.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Ausbruch – startet jetzt die massive FDA-Rallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
50 Leser
Artikel bewerten:
(0)

Infectious Disease Testing Market 2019-2023 Emerging Opportunities in the Americas, EMEA, APAC--A 69-Country Analysis-Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

PUNE, India, January 14, 2019 /PRNewswire/ --

ReportsnReports.com adds 2019-2023 Infectious Disease Testing Market: Emerging Opportunities in the Americas, EMEA, APAC--A 69-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review Report Contains 2,300 pages and 947 tables' reports to its online research library.

The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding Infectious Disease Testing Market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Competitive Assessments:

Abbott, Affymetrix, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Diamedix, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Kreatech/Leica, Lonza, Ortho-Clinical Diagnostics, Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Takara Bio, Thermo Fisher, Wallac/PE, Wako and others.

Get Sample Copy of this Research Report athttps://www.reportsnreports.com/contacts/requestsample.aspx?name=1848762

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Geographic Regions

Asia-Pacific, Europe, Latin America, Middle East, North America

Market Segmentation Analysis

- Sales and market shares of major suppliers of infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:

- Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.

- Companies developing or marketing infectious disease diagnostic products by individual test.

Order a Complete Report of 2019-2023 Infectious Disease Testing Market Research Report athttps://www.reportsnreports.com/purchase.aspx?name=1848762

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Contains 2,300 pages and 947 tables.

Table of Content and List of tables available in report.

Another Related Research Report:

2019-2023 U.S. Infectious Disease Testing Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Direct Purchase of U.S. Infectious Disease Testing Market Report Contains 1,037 pages and 177 tables athttps://www.reportsnreports.com/purchase.aspx?name=1848776 .

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.


Contact:
Vishal Kalra
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1-888-391-5441
sales@reportsandreports.com

Connect With Us on:

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.